Detection of gyrA Mutations in Quinolone-Resistant Salmonella enterica by Denaturing High-Performance Liquid Chromatography
- 1 November 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (11) , 4121-5
- https://doi.org/10.1128/jcm.40.11.4121-4125.2002
Abstract
Denaturing high-performance liquid chromatography (DHPLC) was evaluated as a rapid screening and identification method for DNA sequence variation detection in the quinolone resistance-determining region of gyrA from Salmonella serovars. A total of 203 isolates of Salmonella were screened using this method. DHPLC analysis of 14 isolates representing each type of novel or multiple mutations and the wild type were compared with LightCycler-based PCR-gyrA hybridization mutation assay (GAMA) and single-strand conformational polymorphism (SSCP) analyses. The 14 isolates gave seven different SSCP patterns, and LightCycler detected four different mutations. DHPLC detected 11 DNA sequence variants at eight different codons, including those detected by LightCycler or SSCP. One of these mutations was silent. Five isolates contained multiple mutations, and four of these could be distinguished from the composite sequence variants by their DHPLC profile. Seven novel mutations were identified at five different loci not previously described in quinolone-resistant salmonella. DHPLC analysis proved advantageous for the detection of novel and multiple mutations. DHPLC also provides a rapid, high-throughput alternative to LightCycler and SSCP for screening frequently occurring mutations.Keywords
This publication has 14 references indexed in Scilit:
- Comparison of gyrA Mutations, Cyclohexane Resistance, and the Presence of Class I Integrons in Salmonella enterica from Farm Animals in England and WalesJournal of Clinical Microbiology, 2002
- Fluoroquinolone resistance inSalmonellaserovars isolated from humans and food animalsFEMS Microbiology Reviews, 2002
- Molecular Detection of Antimicrobial ResistanceClinical Microbiology Reviews, 2001
- Determination of minimum inhibitory concentrationsJournal of Antimicrobial Chemotherapy, 2001
- Use of a LightCycler gyrA Mutation Assay for Rapid Identification of Mutations Conferring Decreased Susceptibility to Ciprofloxacin in Multiresistant Salmonella enterica Serotype Typhimurium DT104 IsolatesJournal of Clinical Microbiology, 2001
- Characterization ofgyrAmutations associated with fluoroquinolone resistance inCampylobacter coliby DNA sequence analysis and MAMA PCRFEMS Microbiology Letters, 2000
- Comparative Studies of Mutations in Animal Isolates and Experimental In Vitro- and In Vivo-Selected Mutants of Salmonella spp. Suggest a Counterselection of Highly Fluoroquinolone-Resistant Strains in the FieldAntimicrobial Agents and Chemotherapy, 1999
- PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancersOncogene, 1998
- Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United KingdomJournal of Antimicrobial Chemotherapy, 1998
- Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutationsAntimicrobial Agents and Chemotherapy, 1995